Our Projects
MRNA Technology Transfer Programme
12 April 2022VaxPaL
08 June 2021News & Press Releases » News
MPP welcomes WHO announcement of the first COVID-19 mRNA vaccine technology transfer hub to be established in South Africa
22 June 2021News & Press Releases » Press Releases
The Medicines Patent Pool (MPP) and MSD enter into licence agreement for molnupiravir, an investigational oral antiviral COVID-19 medicine, to increase broad access in low- and middle- income countries
27 October 2021News & Press Releases » Press Releases